Literature DB >> 19550349

An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia.

Lutgarde Lynen1, Sokkab An, Olivier Koole, Sopheak Thai, Seilavath Ros, Paul De Munter, Delphine Sculier, Line Arnould, Katrien Fransen, Joris Menten, Marleen Boelaert, Jef Van den Ende, Robert Colebunders.   

Abstract

OBJECTIVE: To develop an algorithm for optimal use of viral load testing in patients with suspected first-line antiretroviral treatment (ART) failure.
METHODS: Data from a cohort of patients on first-line ART in Cambodia were analyzed in a cross-sectional way to detect markers for treatment failure. Markers with an adjusted likelihood ratio <0.67 or >1.5 were retained to calculate a predictor score. The accuracy of a 2-step algorithm based on this score followed by targeted viral load testing was compared with World Health Organization criteria for suspected treatment failure.
RESULTS: One thousand eight hundred three viral load measurements of 764 patients were available for analysis. Prior ART exposure, CD4 count below baseline, 25% and 50% drop from peak CD4 count, hemoglobin drop of > or =1 g/dL, CD4 count <100 cells per microliter after 12 months of treatment, new onset of papular pruritic eruption, and visual analog scale <95% were included in the predictor score. A score >or=2 had the best combination of sensitivity and specificity and required confirmatory viral load testing for only 9% of patients. World Health Organization criteria had a similar sensitivity but a lower specificity and required viral load testing for 24.9% of patients.
CONCLUSION: An algorithm combining a predictor score with targeted viral load testing in patients with an intermediate probability of failure optimizes the use of scarce resources.

Entities:  

Mesh:

Year:  2009        PMID: 19550349     DOI: 10.1097/QAI.0b013e3181af6705

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  23 in total

1.  Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa.

Authors:  Michael Abouyannis; Joris Menten; Agnes Kiragga; Lutgarde Lynen; Gavin Robertson; Barbara Castelnuovo; Yukari C Manabe; Steven J Reynolds; Lesley Roberts
Journal:  AIDS       Date:  2011-08-24       Impact factor: 4.177

2.  Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.

Authors:  Manuel Koller; Geoffrey Fatti; Benjamin H Chi; Olivia Keiser; Christopher J Hoffmann; Robin Wood; Hans Prozesky; Kathryn Stinson; Janet Giddy; Portia Mutevedzi; Matthew P Fox; Matthew Law; Andrew Boulle; Matthias Egger
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

3.  Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy.

Authors:  Isaac Singini; Thomas B Campbell; Laura M Smeaton; Nagalingeswaran Kumarasamy; Alberto La Rosa; Sineenart Taejareonkul; Steven A Safren; Timothy P Flanigan; James G Hakim; Michael D Hughes
Journal:  HIV Clin Trials       Date:  2016-07-29

4.  Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring.

Authors:  Maya L Petersen; Erin LeDell; Joshua Schwab; Varada Sarovar; Robert Gross; Nancy Reynolds; Jessica E Haberer; Kathy Goggin; Carol Golin; Julia Arnsten; Marc I Rosen; Robert H Remien; David Etoori; Ira B Wilson; Jane M Simoni; Judith A Erlen; Mark J van der Laan; Honghu Liu; David R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

5.  Optimal Allocation of Gold Standard Testing under Constrained Availability: Application to Assessment of HIV Treatment Failure.

Authors:  Tao Liu; Joseph W Hogan; Lisa Wang; Shangxuan Zhang; Rami Kantor
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

6.  Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.

Authors:  Andreas D Haas; Olivia Keiser; Eric Balestre; Steve Brown; Emmanuel Bissagnene; Cleophas Chimbetete; François Dabis; Mary-Ann Davies; Christopher J Hoffmann; Patrick Oyaro; Rosalind Parkes-Ratanshi; Steven J Reynolds; Izukanji Sikazwe; Kara Wools-Kaloustian; D Marcel Zannou; Gilles Wandeler; Matthias Egger
Journal:  Lancet HIV       Date:  2015-06-16       Impact factor: 12.767

7.  A targeted approach for routine viral load monitoring in Malawian adults on antiretroviral therapy.

Authors:  Randy G Mungwira; Titus H Divala; Osward M Nyirenda; Maxwell Kanjala; Francis Muwalo; Felix A Mkandawire; Augustine Choko; Terrie E Taylor; Jane Mallewa; Joep J van Oosterhout; Miriam K Laufer; Matthew B Laurens
Journal:  Trop Med Int Health       Date:  2018-03-30       Impact factor: 2.622

8.  Timing of antiretroviral therapy in Cambodian hospital after diagnosis of tuberculosis: impact of revised WHO guidelines.

Authors:  Kimcheng Choun; Reaksmey Pe; Sopheak Thai; Natalie Lorent; Lutgarde Lynen; Johan van Griensven
Journal:  Bull World Health Organ       Date:  2012-12-12       Impact factor: 9.408

9.  HIV viral suppression in TREAT Asia HIV Observational Database enrolled adults on antiretroviral therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.

Authors:  David C Boettiger; Vohith Khol; Nicolas Durier; Matthew Law; Ly Penh Sun
Journal:  Antivir Ther       Date:  2016-04-28

10.  A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohort.

Authors:  David C Boettiger; Vonthanak Saphonn; Man Po Lee; Praphan Phanuphak; Thuy Thanh Pham; Benedict Lim Heng Sim; Nagalingeswaran Kumarasamy; Kinh Van Nguyen; Pacharee Kantipong; Adeeba Kamarulzaman; Romanee Chaiwarith; Sasisopin Kiertiburanakul; Matthew G Law
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.